ANO1 (Anoctamin 1 (TMEM16A))
Overview
flowchart TD
ANO1["ANO1"] -->|"activates"| Als["Als"]
ANO1["ANO1"] -->|"activates"| Ms["Ms"]
ANO1["ANO1"] -->|"activates"| PI3K["PI3K"]
ANO1["ANO1"] -->|"activates"| Akt["Akt"]
ANO1["ANO1"] -->|"activates"| Cholesterol["Cholesterol"]
ANO1["ANO1"] -->|"participates in"| PI3K_AKT_mTOR_signaling["PI3K-AKT-mTOR signaling"]
CTNNB1["CTNNB1"] -->|"activates"| ANO1["ANO1"]
PI3K["PI3K"] -->|"activates"| ANO1["ANO1"]
AKT["AKT"] -->|"activates"| ANO1["ANO1"]
EGFR["EGFR"] -->|"activates"| ANO1["ANO1"]
style ANO1 fill:#4fc3f7,stroke:#333,color:#000
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ANO1 (Anoctamin 1 (TMEM16A))</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>ANO1</td>
</tr>
<tr>
<td class="label">Alternative Symbols</td>
<td>TMEM16A, DOG1, OAT1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>11q13</td>
</tr>
<tr>
<td class="label">Category</td>
<td>Ion Channel</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Anoctamin/TMEM16</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">10 edges</a></td>
</tr>
</table>
...ANO1 (Anoctamin 1 (TMEM16A))
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ANO1 (Anoctamin 1 (TMEM16A))</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>ANO1</td>
</tr>
<tr>
<td class="label">Alternative Symbols</td>
<td>TMEM16A, DOG1, OAT1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>11q13</td>
</tr>
<tr>
<td class="label">Category</td>
<td>Ion Channel</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Anoctamin/TMEM16</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">10 edges</a></td>
</tr>
</table>
Anoctamin 1 (ANO1), also known as TMEM16A, is a gene encoding a calcium-activated chloride channel (CaCC) that plays critical roles in epithelial secretion, neuronal excitability, and cell proliferation. ANO1 is widely expressed in various tissues, including the gastrointestinal tract, respiratory epithelium, and sensory [neurons](/entities/neurons). In the brain, ANO1 is expressed in regions involved in pain transduction, olfactory bulb, and cortical neurons, where it contributes to neuronal signaling and may play roles in neurodegenerative processes.
Function
Calcium-Activated Chloride Channel Activity
ANO1 encodes a calcium-activated chloride channel that mediates chloride ion flux across cell membranes in response to intracellular calcium elevation. This channel is distinct from voltage-gated chloride channels (CLCNs) and represents a major pathway for calcium-dependent chloride conductance in epithelial and neuronal cells[@hartmann2022].
Expression Pattern
In the brain, ANO1 is expressed in:
- Olfactory bulb — involved in olfactory signal processing
- Cortical neurons — contributes to neuronal excitability
- Sensory neurons — particularly in dorsal root ganglion (DRG) neurons
- [Hippocampus](/brain-regions/hippocampus) — potential role in learning and memory
- Substantia nigra — region affected in Parkinson's disease[@patteson2021]
Cellular Mechanisms
ANO1 activation leads to membrane depolarization due to chloride efflux, which can modulate:
- Action potential firing in neurons
- Neurotransmitter release at synapses
- Calcium signaling through voltage-gated calcium channel modulation
- Neuronal plasticity mechanisms
Role in Neurodegeneration
Alzheimer's Disease
Emerging research suggests ANO1 may play a role in Alzheimer's disease pathogenesis through several mechanisms:
Calcium dysregulation — AD is characterized by disrupted calcium homeostasis. ANO1 contributes to abnormal calcium signaling in neurons, potentially accelerating [amyloid-beta](/proteins/amyloid-beta) toxicity and [tau](/proteins/tau) pathology[@zhang2023].
Neuronal excitability — Altered chloride homeostasis via ANO1 may affect neuronal network activity and contribute to hyperexcitability observed in early AD.
Neuroinflammation — ANO1 expression in [microglia](/cell-types/microglia-neuroinflammation) may modulate inflammatory responses, though this pathway is not well-characterized.Parkinson's Disease
ANO1 is expressed in the substantia nigra pars compacta, the primary brain region degenerating in PD:
Dopaminergic neuron vulnerability — Calcium dysregulation is a key contributor to dopaminergic neuron death. ANO1-mediated chloride currents may interact with calcium signaling pathways in these neurons[@patteson2021].
Motor control circuits — ANO1 in basal ganglia circuits could affect motor neuron excitability and contribute to PD motor symptoms.
Potential therapeutic target — Modulating ANO1 activity may represent a novel approach to neuroprotection in PD, though this remains speculative.Amyotrophic Lateral Sclerosis (ALS)
Preliminary studies suggest ANO1 expression may be altered in motor neuron disease, though the functional significance is unclear.
Therapeutic Implications
Drug Development
ANO1 modulators are being investigated for various applications:
- Blockers — Anthracenone derivatives and benzoic acids have shown promise in blocking ANO1 currents
- Activators — Calcium-independent activators are under development
Challenges
Isoform selectivity — ANO1 belongs to a family of 10 anoctamins with overlapping expression patterns
[Blood-brain barrier](/entities/blood-brain-barrier) — Drug delivery to CNS remains a challenge
Side effects — ANO1 is widely expressed in peripheral tissues, leading to potential off-target effectsSee Also
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Calcium dysregulation and neuronal loss in AD
- [Parkinson's Disease](/diseases/parkinsons-disease) — Substantia nigra degeneration and motor symptoms
- [Calcium Signaling](/entities/calcium-signaling) — Intracellular calcium homeostasis in neurons
- [Ion Channels](/entities/ion-channels) — Overview of neuronal ion channels
- [ANO6](/genes/ano6) — Anoctamin 6 with dual CaCC and phospholipid scramblase function
References
[Hartmann et al., Structure and mechanism of the calcium-activated chloride channel TMEM16A (ANO1), Journal of Molecular Biology (2022) (2022)](https://doi.org/10.1016/j.jmb.2022.167123)
[Patteson et al., Calcium-activated chloride channels in the substantia nigra and their role in Parkinson's disease, Neurobiology of Disease (2021) (2021)](https://doi.org/10.1016/j.nbd.2021.105283)
[Zhang et al., Dysregulation of calcium homeostasis in Alzheimer's disease: Role of TMEM16A, Cell Calcium (2023) (2023)](https://doi.org/10.1016/j.ceca.2023.102689)Pathway Diagram
The following diagram shows the key molecular relationships involving ANO1 (Anoctamin 1 (TMEM16A)) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Disease Associations
Source: Open Targets Platform (opentargets.org)
| Disease | Association Score | Disease ID |
|--------|-------------------|------------|
| Diarrhea | 0.5301 | HP_0002014 |
| moyamoya disease 7 | 0.5179 | MONDO_0958202 |
| Abnormality of the skeletal system | 0.4933 | HP_0000924 |
| diverticular disease | 0.4212 | EFO_0009959 |
| colorectal cancer | 0.4032 | MONDO_0005575 |